Poseida Therapeutics, Inc. Poseida Therapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of P-PSMA-101 Autologous CAR-T for Metastatic Castration-Resistant Prostate Cancer May 20, 2020
Read More
FIZE Medical Ltd. Rapha Capital Management Leads Series A Financing for FIZE Medical Ltd FIZE’s Novel Device Conquers the Last Frontier in Patient Monitoring May 4, 2020